Technology | May 30, 2012

FDA Clears MRI-Guided Radiation Therapy System

May 30, 2012 — ViewRay Inc., a privately held medical device company, has received U.S. Food and Drug Administration (FDA) 510(k) premarket notification clearance for its magnetic resonance guided (MRI)-guided radiation therapy system. The ViewRay system features a unique combination of radiotherapy delivery and simultaneous MRI for the treatment of cancer. ViewRay's treatment planning and delivery software received 510(k) premarket notification clearance in 2011.

"FDA clearance of our integrated system is a major milestone in the development of our technology," said ViewRay president and CEO Gregory M. Ayers, M.D., Ph.D. "It has already been an exciting year for ViewRay, with an additional round of funding and the installation of our first research systems at major U.S. medical centers. Early clinical imaging studies have verified the quality of the system's MR images, and now we're looking forward to clinical applications." The ViewRay system provides continuous soft-tissue imaging during treatment so that clinicians can see and record precisely where radiation therapy is being delivered, as it's being delivered.

ViewRay's patented cancer treatment technology was invented by company founder James F. Dempsey, Ph.D., while he was a member of the radiation oncology faculty at the University of Florida. "ViewRay began with the idea that we need to see what exactly we're doing when we treat cancer patients with radiation therapy," said Dempsey, now ViewRay's chief scientific officer. "Thanks to our clear vision, an outstanding engineering team and dedicated leadership, we're now able to bring that idea into the clinic, where it can help cancer patients."

ViewRay recently closed the final tranche of a $45 million round of Series C venture capital financing intended to advance the ViewRay system toward commercialization. The first ViewRay system is installed at the Siteman Cancer Center at Barnes?Jewish Hospital and Washington University School of Medicine, where early imaging studies have taken place. Additional ViewRay partners include the UCLA Jonsson Comprehensive Cancer Center and the University of Wisconsin Carbone Cancer Center, where a ViewRay system is currently being installed.

For more information: www.viewray.com

Related Content

American College of Radiology Releases New Patient-Oriented Appropriateness Criteria Summaries
News | Patient Engagement | January 19, 2018
January 19, 2018 — New Appropriateness Criteria (AC) Patient Summaries from the American College of Radiology (ACR) c
First Hospitals Achieve Inter-System Connectivity Across Accuray Radiation Therapy Platforms
News | Radiation Therapy | January 19, 2018
Accuray Inc. announced recently that the Heidelberg University Hospital in Heidelberg, Germany, and Oscar Lambret...
National Clinical Decision Support Company (NDSC) has an exclusive deal with the American College of Radiology (ACR) to provide medical imaging appropriate use criteria (AUC).

National Clinical Decision Support Company (NDSC) has an exclusive deal with the American College of Radiology (ACR) to provide medical imaging appropriate use criteria (AUC). 

Feature | Clinical Decision Support | January 18, 2018
January 18, 2018 — Change Healthcare announced the acquisition of National Decision Support Company (NDSC), a leader
RayStation Selected for New Carbon Ion Therapy Center in Japan
News | Treatment Planning | January 18, 2018
January 18, 2018 – RayStation has been chosen as the treatment planning system for a new carbon-ion therapy facility
Raysearch Receives First Order for the Raycare Oncology Information System
News | Oncology Information Management Systems (OIMS) | January 18, 2018
January 18, 2018 – Anderson Regional Cancer Center (ARCC) in Meridian, Mississippi, has placed the first order for...
Philips Introduces Technology Maximizer Program for Imaging Equipment Upgrades
Technology | Imaging | January 17, 2018
January 17, 2018 — Philips recently announced the launch of Technology Maximizer, a cross-modality program designed t
RSNA 2017 Celebrates Innovation in Radiology
News | Imaging | January 15, 2018
January 15, 2018 — The Radiological Society of North America’s...

Size comparison between 3-D printed prosthesis implant and a penny.

News | 3-D Printing | January 11, 2018
January 11, 2018 — Researchers using...
RSNA 2017 technical exhibits, expo floor, showing new radiology technology advances.
Feature | RSNA 2017 | January 11, 2018
January 11, 2018 — Here is a list of some of the key clinical study presentations, articles on trends and videos from
The artificial intelligence (AI) smart algorithm onboard the Infervision stroke product calculates the volume of bleed on the basis of multiple brain CT slices.

The AI smart algorithm onboard the Infervision stroke product calculates the volume of bleed on the basis of multiple brain CT slices. The size of the bleed volume indicates the urgency and type of treatment required.

Feature | Artificial Intelligence | January 10, 2018 | Greg Freiherr
Exhibitors at the 2017 Radiological Society of North American (RSNA) meeting rode the...
Overlay Init